{
  "url": "https://en.wikipedia.org/wiki/Lundbeck",
  "title": "Lundbeck",
  "header": [
    [
      "Brand name",
      []
    ],
    [
      "INN",
      [
        "/wiki/International_Nonproprietary_Name"
      ]
    ],
    [
      "Drug class",
      []
    ],
    [
      "Indication ( s )",
      [
        "/wiki/Indication_(medicine)"
      ]
    ],
    [
      "Notes",
      []
    ]
  ],
  "data": [
    [
      [
        "Abilify Maintena",
        []
      ],
      [
        "Aripiprazole",
        [
          "/wiki/Aripiprazole"
        ]
      ],
      [
        "Atypical antipsychotic",
        [
          "/wiki/Atypical_antipsychotic"
        ]
      ],
      [
        "Maintenance treatment of schizophrenia",
        [
          "/wiki/Schizophrenia"
        ]
      ],
      [
        "Co-marketed with Otsuka",
        [
          "/wiki/Otsuka_Pharmaceutical"
        ]
      ]
    ],
    [
      [
        "Azilect",
        []
      ],
      [
        "Rasagiline",
        [
          "/wiki/Rasagiline"
        ]
      ],
      [
        "MAO B inhibitor",
        [
          "/wiki/Monoamine_oxidase_B",
          "/wiki/Monoamine_oxidase_inhibitor"
        ]
      ],
      [
        "Parkinson 's disease",
        [
          "/wiki/Parkinson's_disease"
        ]
      ],
      [
        "In some countries co-marketed with Teva",
        [
          "/wiki/Teva_Pharmaceutical_Industries"
        ]
      ]
    ],
    [
      [
        "Brintellix , Trintellix",
        []
      ],
      [
        "Vortioxetine",
        [
          "/wiki/Vortioxetine"
        ]
      ],
      [
        "SRI multimodal antidepressant ( described as serotonin modulator and stimulator )",
        [
          "/wiki/Serotonin_reuptake_inhibitor"
        ]
      ],
      [
        "Major depressive disorder",
        [
          "/wiki/Major_depressive_disorder"
        ]
      ],
      [
        "Co-marketed in the USA with Takeda , who also has rights to Japan",
        []
      ]
    ],
    [
      [
        "Cipramil , Celexa , Seropram",
        []
      ],
      [
        "Citalopram",
        [
          "/wiki/Citalopram"
        ]
      ],
      [
        "SSRI",
        [
          "/wiki/SSRI"
        ]
      ],
      [
        "Major depressive disorder Anxiety disorders",
        [
          "/wiki/Major_depressive_disorder",
          "/wiki/Anxiety_disorders"
        ]
      ],
      [
        "",
        []
      ]
    ],
    [
      [
        "Cipralex , Lexapro",
        []
      ],
      [
        "Escitalopram",
        [
          "/wiki/Escitalopram"
        ]
      ],
      [
        "SSRI",
        []
      ],
      [
        "Major depressive disorder Generalized anxiety disorder ( GAD )",
        [
          "/wiki/Generalized_anxiety_disorder"
        ]
      ],
      [
        "( S ) - enantiomer of citalopram",
        [
          "/wiki/Enantiomer"
        ]
      ]
    ],
    [
      [
        "Clopixol , Cisordinol",
        []
      ],
      [
        "Zuclopenthixol",
        [
          "/wiki/Zuclopenthixol"
        ]
      ],
      [
        "High-potency typical antipsychotic ( of thioxanthene class )",
        [
          "/wiki/Typical_antipsychotic",
          "/wiki/Thioxanthene"
        ]
      ],
      [
        "Psychoses , including schizophrenia",
        []
      ],
      [
        "Cis -isomer of clopenthixol ( a predecessor drug )",
        [
          "/wiki/Cis\u2013trans_isomerism",
          "/wiki/Clopenthixol"
        ]
      ]
    ],
    [
      [
        "Deanxit",
        []
      ],
      [
        "Flupentixol/melitracen",
        [
          "/wiki/Flupentixol/melitracen"
        ]
      ],
      [
        "Typical antipsychotic / Tricyclic antidepressant",
        [
          "/wiki/Tricyclic_antidepressant"
        ]
      ],
      [
        "Moderate-to-severe depression associated with anxiety and/or agitation",
        []
      ],
      [
        "",
        []
      ]
    ],
    [
      [
        "Ebixa , Ebix",
        []
      ],
      [
        "Memantine",
        [
          "/wiki/Memantine"
        ]
      ],
      [
        "NMDA receptor antagonist",
        [
          "/wiki/NMDA_receptor_antagonist"
        ]
      ],
      [
        "Alzheimer 's disease",
        [
          "/wiki/Alzheimer's_disease"
        ]
      ],
      [
        "",
        []
      ]
    ],
    [
      [
        "Fluanxol",
        []
      ],
      [
        "Flupentixol",
        [
          "/wiki/Flupentixol"
        ]
      ],
      [
        "High-potency thioxanthene typical antipsychotic",
        []
      ],
      [
        "Psychoses , including schizophrenia",
        []
      ],
      [
        "",
        []
      ]
    ],
    [
      [
        "Modiodal",
        []
      ],
      [
        "Modafinil",
        [
          "/wiki/Modafinil"
        ]
      ],
      [
        "Eugeroic ( wakefulness-promoting agent )",
        [
          "/wiki/Wakefulness-promoting_agent"
        ]
      ],
      [
        "Narcolepsy Shift work sleep disorder Obstructive sleep apnea / hypopnea",
        [
          "/wiki/Narcolepsy",
          "/wiki/Shift_work_sleep_disorder",
          "/wiki/Sleep_apnea",
          "/wiki/Hypopnea"
        ]
      ],
      [
        "",
        []
      ]
    ],
    [
      [
        "Nortrilen , Sensoval",
        []
      ],
      [
        "Nortriptyline",
        [
          "/wiki/Nortriptyline"
        ]
      ],
      [
        "Tricyclic antidepressant",
        [
          "/wiki/Tricyclic_antidepressant"
        ]
      ],
      [
        "Depression Nocturnal enuresis",
        [
          "/wiki/Nocturnal_enuresis"
        ]
      ],
      [
        "Active metabolite of amitriptyline",
        []
      ]
    ],
    [
      [
        "Onfi",
        []
      ],
      [
        "Clobazam",
        [
          "/wiki/Clobazam"
        ]
      ],
      [
        "Benzodiazepine anticonvulsant and anxiolytic",
        [
          "/wiki/Benzodiazepine",
          "/wiki/Anticonvulsant",
          "/wiki/Anxiolytic"
        ]
      ],
      [
        "Seizures associated with Lennox-Gastaut syndrome",
        [
          "/wiki/Lennox-Gastaut_syndrome"
        ]
      ],
      [
        "Outside the US , approved for anxiety and treatment-resistant epilepsy ( under the brand name Frisium )",
        []
      ]
    ],
    [
      [
        "Rexulti",
        []
      ],
      [
        "Brexpiprazole",
        [
          "/wiki/Brexpiprazole"
        ]
      ],
      [
        "Atypical antipsychotic ( the so-called serotonin-dopamine activity modulator )",
        []
      ],
      [
        "Schizophrenia Major depressive disorder ( as an adjunctive treatment )",
        [
          "/wiki/Schizophrenia",
          "/wiki/Major_depressive_disorder"
        ]
      ],
      [
        "Marketed in partnership with Otsuka",
        [
          "/wiki/Otsuka_Pharmaceutical"
        ]
      ]
    ],
    [
      [
        "Sabril",
        []
      ],
      [
        "Vigabatrin",
        [
          "/wiki/Vigabatrin"
        ]
      ],
      [
        "Anticonvulsant ( GABA transaminase inhibitor )",
        [
          "/wiki/GABA_transaminase"
        ]
      ],
      [
        "Treatment-resistant epilepsy ( complex partial seizures and West syndrome )",
        [
          "/wiki/West_syndrome"
        ]
      ],
      [
        "Use is restricted to resistant and refractory epilepsy due to the risk of irreversible vision loss",
        []
      ]
    ],
    [
      [
        "Saphris , Sycrest",
        []
      ],
      [
        "Asenapine",
        [
          "/wiki/Asenapine"
        ]
      ],
      [
        "Atypical antipsychotic",
        [
          "/wiki/Atypical_antipsychotic"
        ]
      ],
      [
        "Psychoses , including schizophrenia Acute and maintenance treatment of Bipolar I disorder",
        [
          "/wiki/Bipolar_I_disorder"
        ]
      ],
      [
        "In some countries ( like Philippines , Latvia and Russian Federation ) marketed by or co-marketed with Merck & Co. ( Merck Sharp & Dohme )",
        [
          "/wiki/Merck_&_Co."
        ]
      ]
    ],
    [
      [
        "Saroten , Sarotex , Redomex",
        []
      ],
      [
        "Amitriptyline",
        [
          "/wiki/Amitriptyline"
        ]
      ],
      [
        "Tricyclic antidepressant",
        []
      ],
      [
        "Depression ( both unipolar and bipolar ) Anxiety disorders Eating disorders Migraine prophylaxis Insomnia , etc",
        [
          "/wiki/Major_depressive_disorder",
          "/wiki/Bipolar_disorder",
          "/wiki/Eating_disorders",
          "/wiki/Prevention_of_migraines",
          "/wiki/Insomnia"
        ]
      ],
      [
        "",
        []
      ]
    ],
    [
      [
        "Selincro",
        []
      ],
      [
        "Nalmefene",
        [
          "/wiki/Nalmefene"
        ]
      ],
      [
        "Opioid receptor antagonist",
        [
          "/wiki/Opioid_antagonist"
        ]
      ],
      [
        "Reduction of alcohol consumption in alcohol dependence ( in combination with psychosocial support )",
        [
          "/wiki/Alcoholism"
        ]
      ],
      [
        "Only be used in patients with high drinking risk ( at initial assessment and 2 weeks later ) , in those who do not have physical withdrawal symptoms or require immediate detoxification",
        [
          "/wiki/Alcohol_withdrawal_syndrome",
          "/wiki/Alcohol_detoxification"
        ]
      ]
    ],
    [
      [
        "Serdolect , Serlect",
        []
      ],
      [
        "Sertindole",
        [
          "/wiki/Sertindole"
        ]
      ],
      [
        "Atypical antipsychotic",
        [
          "/wiki/Atypical_antipsychotic"
        ]
      ],
      [
        "Psychoses , including schizophrenia",
        []
      ],
      [
        "",
        []
      ]
    ],
    [
      [
        "Treanda",
        []
      ],
      [
        "Bendamustine",
        [
          "/wiki/Bendamustine"
        ]
      ],
      [
        "Nitrogen mustard alkylating agent",
        [
          "/wiki/Nitrogen_mustard",
          "/wiki/Alkylating_antineoplastic_agent"
        ]
      ],
      [
        "Chronic lymphocytic leukemia",
        [
          "/wiki/Chronic_lymphocytic_leukemia"
        ]
      ],
      [
        "Co-marketed with Teva",
        [
          "/wiki/Teva_Pharmaceutical_Industries"
        ]
      ]
    ],
    [
      [
        "Truxal",
        []
      ],
      [
        "Chlorprothixene",
        [
          "/wiki/Chlorprothixene"
        ]
      ],
      [
        "Thioxanthene typical antipsychotic",
        []
      ],
      [
        "Psychosis , including schizophrenia",
        []
      ],
      [
        "In some other countries approved for menopausal depression , insomnia and resistant nausea/vomiting",
        [
          "/wiki/Menopause"
        ]
      ]
    ]
  ],
  "section_title": "Key products",
  "section_text": "Lundbeck markets a number of different pharmaceuticals for the treatment of psychiatric and neurological disorders . The most recently launched compounds include : Rexulti ( depression and schizophrenia ) , Brintellix ( depression ) and Abilify Maintena ( schizophrenia and bipolar 1 ) . Lundbeck manufactures drugs such as :",
  "uid": "Lundbeck_0",
  "intro": "H. Lundbeck A/S (commonly known simply as Lundbeck) is a Danish international pharmaceutical company engaged in the research and development, production, marketing, and sale of drugs for the treatment of disorders in the central nervous system (CNS), including depression, schizophrenia, Alzheimer's disease and Parkinson's disease. Headquartered in Copenhagen, Denmark, Lundbeck has international production facilities in Denmark, Italy and France and affiliates or sales offices in more than 50 countries. Lundbeck employs around 5,000 people globally (as of 2017), and the companys products are registered in more than 100 countries worldwide. In 2017, the company's revenue was DKK 17.2 billion (\u20ac2.3 billion). Lundbeck is listed on the Copenhagen Stock Exchange (CSE). Lundbeck is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)"
}